Board of Directors
Peter Wehrly
Executive Chairman of the Board
Over the past 15 years, he has held CEO, President, and Chairman roles at growth-stage companies including Vivex Biologics, Synaptive Medical, and PQ Bypass, and served as Board Member and President at Premia Spine. He has guided novel technologies through CE Mark and PMA approval, built commercial infrastructures, secured major hospital system contracts, developed strategic alliances, and supported successful acquisitions. He also led Medingo in Israel through operational scaling and strategic sale to Roche. He currently serves as Board Advisor to Premier Spine.
Earlier in his career, Mr. Wehrly served in senior executive leadership roles at Medtronic and Covidien, managing multi-billion-dollar global business units. At Covidien, he led the Respiratory & Monitoring Solutions division, including the Patient Monitoring business, driving commercialization, strategic acquisitions, and global expansion of advanced monitoring technologies.
He brings deep expertise in commercialization strategy, regulatory execution, partnership development, and disciplined operational growth.
Dr. Alan Levy
Board Member
He then established and led multiple medical device companies, including Heartstream, that developed the first small, lightweight and easy-to-use automated external defibrillator.
Dr. Levy has also served as a Senior Advisor at Frazier Healthcare Ventures. He currently serves on the boards of multiple private and public healthcare companies.
Dr. Levy holds a BSc in Chemistry from City College of New York and a PhD and Honorary DSc from Purdue University.
Josep Ll. Sanfeliu
Board MembeR
Previously Josep has worked in the pharmaceutical industry as Corporate Development Director at Almirall where he was involved with business development and in charge of M&A and corporate investments and also worked as General Manager leading operations in the segment of home-healthcare services at DomusVi.
Dr. Shmuel Cabilly
Board Member
Today there are already twenty drugs in the market based on this technology among which are Herceptin, Rituxan, Traceba, Raptiva, Xolair and more. Dr. Cabilly was also a co-founder and a chief scientist of Ethrog Biotechnology where he invented major technologies in the field of chemistry.
Amir Lahat
Board Member
He is Founding General Partner at Olive Tree Ventures, a firm investing in digital health and enterprise companies, focusing on Israeli related early-growth stage investments. Prior to OTV Mr. Lahat joined Nokia Siemens Networks in 2008 following the acquisition of Atrica, a carrier-ethernet company that he had co-founded. At Nokia, he served as Director of Product Management and Vice President of Business Development and Solutions. He headed Nokia’s global business ventures, establishing 12 internal startups and building the foundation for the company’s cloud business. He is also a co-founder of Dyyno and has held executive and technical roles at 3Com/NiceCom and Nortel/Telrad. He holds 11 granted patents in communication and IT domains.
Mr. Lahat holds a B.Sc. in Engineering and MBA from Tel Aviv University, and is a Kauffman fellow.
Maite Malet
Board Member
Previously, she was incubating tech companies (healthtech, insurtech, wellness, etc.) at Antai Ventures, leading venture builder in Southern Europe. Maite started her professional career at Deloitte Corporate Finance, unit responsible for M&A and debt restructuring operations in Spain.
Currently doing a graduate program at Harvard University in Corporate Innovation and Sustainability, Maite holds a bachelor’s degree in International Business from Pompeu Fabra University (UPF) and the University of Florida (Warrington College of Business), and a master’s degree in Digital Marketing by ISDI.
Shelly Segal
Board Member
Prior to BASE Investments, Shelly was Co-Founder and CEO of Vascutech Solutions and served as Director at Simedica. Throughout her career, she has worked with entrepreneurs, management teams and growing companies, bringing a strategic and practical business perspective to company development and commercialization.
Shelly studied at the Technion – Israel Institute of Technology.
Henry Weinstein
Board Member
He has a proven track record of launching over 300 products in the pharmaceutical industry in Latin America and completing more than 20 licensing deals including biotech products and medical devices. He currently serves as a Board Member of Convexity Scientific, Via Surgical and Dog Parker. He previously served on the board of BMRC, a biotech research consortium in Chile.
Galit Zuckerman Stark
Founder, CEO and board member
Before founding Medasense she led algorithm teams at Applied Materials and worked at Nokia-Siemens and Nice Systems. Galit started her technology career at the elite Israeli Defense Forces “Haman Talpiot” program. She also served as a consultant for several start-up companies in the field of signal and image processing including BoneTone Communications which was successfully acquired by DSPG Inc in 2011.
Galit holds an MSc degree in Electrical Engineering (cum laude, Engineering Faculty Excellence Program) and a BSc in Computer Engineering (cum laude, Adi Lautman special program for outstanding students TAU) from Tel Aviv University, Israel.
Robert Gavshon
Board Observer
Mr. Gavshon was a significant shareholder in, and served as an Executive Director of private and listed companies which developed icon brands. He has gained broad business experience in Australasia, USA and Asia and has been involved in a number of successful equity ventures where he has also taken Board and advisory roles.
Mr. Gavshon is widely respected for the extensive community service he has given and occupied leading positions in the Australian not-for-profit sector. He holds commerce and law degrees from the University of Witwatersrand, South Africa.
Athar Mirza
Board OBSERVER
He currently serves as the VP of Global Infusions Systems at Baxter, a global medical products company, and has been at Baxter for 15 years with various roles increasing in scope and responsibility.
